CLZNY:OTC-Clariant AG (USD)

COMMON STOCK | Specialty Chemicals | OTC

Last Closing Price

USD 20.70

Change

-0.88 (-4.08)%

Market Cap

USD 7.01B

Volume

250.00

Average Target Price

N/A
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Clariant AG, together with its subsidiaries, develops, manufactures, distributes, and sells specialty chemicals worldwide. It operates in three segments: Care Chemicals, Catalysis, Natural Resources. The company offers flame retardants, performance additives, and advanced surface solutions for use in plastics, coatings, inks, and other applications; and catalysts for the petrochemical and refining, synthesis gas, chemical, emissions control, specialty zeolites and zeolite-based, and custom catalyst markets. It also provides bentonite based specialty products for the oil purification, foundry additive, desiccant, oxygen absorber, humidity indicator, feed additives, civil engineering, waste water treatment, clay specialties, paper and detergent additive, PVC stabilizer, BTX-catalyst, and kerosene and jet fuel purification industries. In addition, the company offers industrial and consumer specialty chemicals and application solutions for the automotive brake fluid and coolant, aircraft anti-itching and deicing fluid, construction chemical, agrochemical and agricultural adjuvants, food ingredients, gas treatment, heat transfer fluid, home care, industrial cleaning, industrial lubricant additive, special solvent, paint and coating, and personal care ingredient markets. Additionally, the company offers oilfield production chemicals for enhanced oil recovery, offshore and deep water, conventional and unconventional oil and gas, heavy oil, paraffin control technologies, and well services additives, as well as Veritrax, an intelligent chemical management system; chemical solutions for the end-to-end mining process; refinery services' additives; biotech and bio-based chemicals, such as sunliquid, which is an agricultural residue converted to cellulosic ethanol; and VitiSpheres encapsulated active ingredients. Clariant AG is headquartered in Muttenz, Switzerland.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-05-13 )

Largest Industry Peers for Specialty Chemicals

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
SKFOF Sika AG

N/A

USD42.81B 52.04 31.78
SXYAY Sika AG

+0.34 (+1.15%)

USD42.57B 51.26 31.78
GVDBF Givaudan SA

N/A

USD39.17B 45.29 32.29
GVDNY Givaudan SA

+1.13 (+1.36%)

USD38.55B 47.19 32.42
NPCPF Nippon Paint Holdings Co., Ltd

N/A

USD36.02B 60.94 0.31
RDSMY Koninklijke DSM N.V

+0.51 (+1.14%)

USD30.61B 50.17 24.15
KDSKF Koninklijke DSM N.V

-0.70 (-0.40%)

USD30.53B 50.40 24.15
AKZOF Akzo Nobel N.V

N/A

USD23.07B 27.10 17.85
AKZOY Akzo Nobel N.V

+0.63 (+1.54%)

USD22.65B 26.00 17.85
EMSHF EMS-CHEMIE HOLDING AG

N/A

USD21.64B 43.17 37.99

ETFs Containing CLZNY

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Specialty Chemicals)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -5.91% 23% F 22% F
Dividend Return 9.65% 89% B+ 95% A
Total Return 3.74% 42% F 33% F
Trailing 12 Months  
Capital Gain 21.98% 25% F 32% F
Dividend Return 20.16% 95% A 93% A
Total Return 42.14% 35% F 42% F
Trailing 5 Years  
Capital Gain 14.94% 38% F 45% F
Dividend Return 26.71% 94% A 81% B-
Total Return 41.64% 44% F 52% F
Average Annual (5 Year Horizon)  
Capital Gain 6.34% 46% F 46% F
Dividend Return 3.17% 69% D+ 61% D-
Total Return 9.50% 45% F 48% F
Risk Return Profile  
Volatility (Standard Deviation) 25.42% 70% C- 71% C-
Risk Adjusted Return 37.38% 63% D 66% D
Market Capitalization 7.01B 72% C- 85% B
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Specialty Chemicals)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 8.49 85% B 72% C-
Price/Book Ratio 2.83 52% F 39% F
Price / Cash Flow Ratio 18.99 20% F 11% F
EV/EBITDA 14.76 43% F 27% F
Management Effectiveness  
Return on Equity 4.59% 41% F 55% F
Return on Invested Capital 3.70% 35% F 57% F
Return on Assets 3.14% 54% F 75% C
Debt to Equity Ratio 63.51% 25% F 29% F
Technical Ratios  
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 1.25 29% F 36% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector